Anifrolumab (brand name Saphnelo) reduced the risk of long-term organ damage progression by about 60% in patients with ...

Lupus can do irreversible harm to a person's organs, damaging the lungs, kidneys, heart, liver and other vital organs through ...

Cabaletta’s new data slice for its investigational CD19-CAR T cell therapy shows “robust benefit” for patients with lupus and ...

Aurinia can still see growth in product revenues from Lupkynis and has a chance to show that AUR200 has some value in 2025.

Read more about the challenges people of color face in healthcare and what the Lupus Foundation America does to address these health disparities. We will be updating this blog throughout Black History ...

Roy Keane's daughter has been hailed as an 'inspirational young lady' after opening up on her excruciating experience with ...

Concentra Biosciences LLC, controlled by San Diego's Tang Capital Partners LP, made an unsolicited offer at $3 per share plus ...

This month we have been discussing mental health and wellness when you have lupus in a four-part blog series. This week we are sharing some strategies on talking about lupus and your experiences.

Biogen has bagged $250 million to advance a key pipeline prospect. | Biogen has bagged $250 million to advance a key pipeline ...

The funding agreement comes as Biogen revealed a modest Q4 sales beat, which analysts expect will be “overshadowed” by the ...

Royalty Pharma has signed a deal to pay Biogen $250m to support the development of its late-stage experimental lupus ...

More than 50% of patients with systemic lupus erythematosus (SLE) develop lupus nephritis (LN) during the disease, which may ...